Determination of Mitochondrial DNA Upon Drug Treatment

BIO-PROTOCOL ◽  
2015 ◽  
Vol 5 (2) ◽  
Author(s):  
Michel Perron ◽  
Joy Feng
Keyword(s):  
Mitochondrial Dna ◽  
Drug Treatment

scholarly journals Species determination of Brazilian mammals implicated in the epidemiology of rabies based on the control region of mitochondrial DNA

2008 ◽  
Vol 12 (6) ◽  
pp. 462-465 ◽  
Author(s):  
Pedro Carnieli Junior ◽  
Willian de Oliveira Fahl ◽  
Juliana Galera Castilho ◽  
Paulo Eduardo Brandão ◽  
Maria Luiza Carrieri ◽  
...  
Keyword(s):  
Mitochondrial Dna ◽  
Control Region ◽  
Species Determination

scholarly journals Determination of the Action Spectrum of UVR-Induced Mitochondrial DNA Damage in Human Skin Cells

2015 ◽  
Vol 135 (10) ◽  
pp. 2512-2518 ◽  
Author(s):  
Jennifer A. Latimer ◽  
James J. Lloyd ◽  
Brian L. Diffey ◽  
Paul J. Matts ◽  
Mark A. Birch-Machin
Keyword(s):  
Dna Damage ◽  
Mitochondrial Dna ◽  
Human Skin ◽  
Action Spectrum ◽  
Skin Cells ◽  
Mitochondrial Dna Damage ◽  
Human Skin Cells

Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis

2018 ◽  
Vol 25 (11) ◽  
pp. 1535-1538 ◽  
Author(s):  
Nicolas Fissolo ◽  
Laura Cervera-Carles ◽  
Luisa María Villar Guimerans ◽  
Alberto Lleó ◽  
Jordi Clarimón ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Cerebrospinal Fluid ◽  
Mitochondrial Dna ◽  
Clinically Isolated Syndrome ◽  
Chain Reaction ◽  
Pathological Conditions ◽  
Polymerase Chain ◽  
Digital Polymerase Chain Reaction

The role of cerebrospinal fluid (CSF) mitochondrial DNA (mtDNA) levels as biomarker in multiple sclerosis (MS) is unknown. We determined CSF mtDNA levels in a cohort of 237 individuals, including patients with MS and clinically isolated syndrome (CIS), inflammatory and non-inflammatory neurological controls, and cognitively healthy controls (HC). mtDNA concentration was measured by droplet digital polymerase chain reaction. CSF mtDNA levels were increased in all pathological conditions compared with HC, though no differences were observed between relapse-onset and progressive MS clinical forms, CIS patients and neurological controls. These findings do not support the determination of CSF mtDNA levels as a useful biomarker in MS clinical practice.

Determination of the blood level of mitochondrial DNA for the prediction of pregnancy complication

2018 ◽  
Vol 2_2018 ◽  
pp. 44-49 ◽  
Author(s):  
Skripnichenko Yu.P. Skripnichenko ◽  
Baranov I.I. Baranov ◽  
Vysokikh M.Yu. Vysokikh ◽  
◽  
◽  
...  
Keyword(s):  
Mitochondrial Dna ◽  
Blood Level ◽  
Pregnancy Complication
Sign in / Sign up

Export Citation Format

Share Document